Sun Pharmaceuticals Industries (BOM:524715) Interest Expense: ₹-3,638 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524715 Sun Pharmaceuticals Industries Ltd BOM:524715
92 GF Score
Price ₹1,900.90
GF Value ₹1,954.87
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries Interest Expense?

Sun Pharmaceuticals Industries BOM:524715 -0.01% 92 Interest Expense is ₹-3,638 Mil as of Jun. 2026. GuruFocus rates BOM:524715 with a GF Score™ of 92/100 and a GF Value™ of ₹1,954.87 (Fairly Valued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sun Pharmaceuticals Industries's interest expense for the three months ended in Jun. 2026 was ₹ -997 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-3,638 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sun Pharmaceuticals Industries's Operating Income for the three months ended in Jun. 2026 was ₹ 35,570 Mil. Sun Pharmaceuticals Industries's Interest Expense for the three months ended in Jun. 2026 was ₹ -997 Mil. Sun Pharmaceuticals Industries's Interest Coverage for the quarter that ended in Jun. 2026 was 35.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharmaceuticals Industries  (BOM:524715) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sun Pharmaceuticals Industries's Interest Expense for the three months ended in Jun. 2026 was ₹-997 Mil. Its Operating Income for the three months ended in Jun. 2026 was ₹35,570 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was ₹0 Mil.

Sun Pharmaceuticals Industries's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*35569.6/-996.7
=35.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sun Pharmaceuticals Industries Interest Expense Historical Data

* Premium members only.

The historical data trend for Sun Pharmaceuticals Industries's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries Interest Expense Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,273.50 -1,720.00 -2,384.70 -2,313.60 -3,389.10

Sun Pharmaceuticals Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -748.00 -998.60 -783.60 -858.90 -996.70
BOM:524715
92GF Score
Sun Pharmaceuticals Industries Ltd BOM:524715
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharmaceuticals Industries Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-3,638 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-3,638 Mil mean?
Sun Pharmaceuticals Industries (BOM:524715) has a Interest Expense of ₹-3,638 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sun Pharmaceuticals Industries and its competitors.
Is Sun Pharmaceuticals Industries' Interest Expense too high?
Sun Pharmaceuticals Industries' current Interest Expense is ₹-3,638 Mil. Overall, Sun Pharmaceuticals Industries has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sun Pharmaceuticals Industries' Interest Expense compare to ZTS and UTHR?
Sun Pharmaceuticals Industries' Interest Expense of ₹-3,638 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sun Pharmaceuticals Industries and its competitors. Sun Pharmaceuticals Industries's current Interest Expense is ₹-3,638 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharmaceuticals Industries stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharmaceuticals Industries (BOM:524715) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,954.87, compared to a current price of ₹1,900.90 — trading 2.8% below its estimated fair value. The current Interest Expense is ₹-3,638 Mil. Sun Pharmaceuticals Industries' overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Sun Pharmaceuticals Industries (BOM:524715), the current Interest Expense is ₹-3,638 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharmaceuticals Industries (BOM:524715) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,900.90 is trading 2.8% below its estimated GF Value™ of ₹1,954.87. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for BOM:524715:

  • Interest Expense: ₹-3,638 Mil
  • GF Value™: ₹1,954.87 vs. price of ₹1,900.90 (2.8% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the BOM:524715 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharmaceuticals Industries Business Description

Other Exchanges SUNPHARMA:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for BOM:524715

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,900.90
Price
₹1,954.87
GF Value